购物车
- 全部删除
- 您的购物车当前为空
CLK-IN-T3 是 CLK1、CLK2 和 CLK3 的抑制剂,IC50 为 0.67、15 和 110 nM。 CLK-IN-T3 具有抗癌活性。
为众多的药物研发团队赋能,
让新药发现更简单!
CLK-IN-T3 是 CLK1、CLK2 和 CLK3 的抑制剂,IC50 为 0.67、15 和 110 nM。 CLK-IN-T3 具有抗癌活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 539 | 现货 | |
2 mg | ¥ 783 | 现货 | |
5 mg | ¥ 1,260 | 现货 | |
10 mg | ¥ 2,180 | 现货 | |
25 mg | ¥ 3,680 | 现货 | |
50 mg | ¥ 5,320 | 现货 | |
100 mg | ¥ 7,480 | 现货 |
产品描述 | CLK-IN-T3 is an inhibitor of CLK1, CLK2, and CLK3 with IC50s of 0.67, 15, and 110 nM. CLK-IN-T3 exhibits anti-cancer activity. |
靶点活性 | CLK2:15 nM, CLK1:0.67 nM, CLK3:110 nM |
体外活性 | CLK-IN-T3 (0.5, 1.0 μM) decreases the phosphorylation of CLK-targeted SR proteins and CLK proteins increase slightly. CLK-IN-T3 (0.1, 0.5, 1.0, 5.0, 10.0 µM) results in mild cell cycle arrest at the G2/M boundary with a long-duration of 24 h. CLK-IN-T3 inhibits DYRK1A and DYRK1B with IC50s of 260 and 230 nM[1]. |
分子量 | 482.58 |
分子式 | C28H30N6O2 |
CAS No. | 2109805-56-1 |
Smiles | CN1CCN(CC1)C(=O)C(C)(C)c1ccc(cc1)C(=O)Nc1cn2cc(ccc2n1)-c1ccncc1 |
密度 | 1.25 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||
溶解度信息 | DMSO: 4.5 mg/mL (9.32 mM), Sonication and heating are recommended. | |||||||||||||||
溶液配制表 | ||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容